FDA Investigator

Claudia M Perez-Kasmarski

Latest inspection on record: El Segundo, United States, May 2026 · records back to 2019

Human DrugsAnimal Drugs & FeedsFoods & CosmeticsMedical Devices & Rad Health

FDA inspection record · Last updated July 12, 2026

Overview

  • 37 inspections across 36 sites are on record.
  • 131 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2026-05-28.

At a glance

Inspections

37

Sites

36

Observations

131

Career since

May 2019

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Pacific Science LLC28 May 2026Medical Devices & Rad HealthOn file
Cardinal Health 414 LLC3 Apr 2026Human DrugsOn file
Cardinal Health, Inc21 Feb 2026Human DrugsOn file
International Medication Systems Ltd.19 Dec 2025Human DrugsOn file
NuSil Technology LLC14 Nov 2025Human Drugs

Sites inspected

Pacific Science LLCEl Segundo, United States1 insp.
Cardinal Health 414 LLCMemphis, United States1 insp.
Cardinal Health, IncHouston, United States1 insp.
International Medication Systems Ltd.South El Monte, United States1 insp.
NuSil Technology LLCBakersfield, United States1 insp.

Co-investigators

Investigators who share inspections with this person.

Lisa Shin3 shared
Eileen A Liu2 shared
Navneet Kaur2 shared
Amir Alavi2 shared
Bryan A Galvez2 shared
Thuy Tram L Nguyen1 shared

Full investigator report

Get the verbatim findings behind Claudia M Perez-Kasmarski's 131 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site

Related investigators